← brief for 2026-10-03 · Slowing decline

CLINICAL AND PATHOGENETIC RATIONALE FOR THE COMBINED USE OF FINERENONE AND EMPAGLIFLOZIN IN PATIENTS WITH DIABETIC NEPHROPATHY AND IMPAIRED RENAL FUNCTION

Article No results yet Not peer reviewed

Key takeaways

A trial is planned to test two drugs together for diabetic kidney disease. The study will include 120 people. There are no results yet because the trial is just starting.

Who did this work

Maratovna Daminova Kamola · Makhmudovna Akhmedova Umida

Source

Article · OpenAlex, Kidney disease concept sweep (verified C2778653478) · 2026-10-02
https://doi.org/10.5281/zenodo.23097615